Robert Choye joined CZ Biohub San Francisco from PACT Pharma, Inc., where he served as Head of Finance and Corporate Controller, leading the company’s financial functions, including accounting, strategic finance, treasury, reporting, and operations.
He brings over 13 years of experience in accounting, primarily focusing on molecular diagnostics and immuno-oncology. In addition to PACT Pharma, he served in other management positions at Counsyl, Inc., which was acquired by Myriad Genetics, Inc., and Invitae, where he played a key role in their IPO in early 2015. Choye began his career in public accounting, most notably with Ernst & Young, where he primarily served the life science and biotech industries.
Choye is a Certified Public Accountant with the California Board of Accountancy, and member of the California Society of Certified Public Accountants. He received his B.S. in business administration from San Jose State University’s Lucas School of Business.
